Loading company details...
Latest Form 4 (Nov 4, 2026): Jeremy Yarwood (Chief Scientific Officer): Exercise/Conversion of 16,207 shares, $191.6K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Jeremy Yarwood, Chief Scientific Officer | Exercise/Conversion | 16,207 | $191.6K |
| Nov 3, 2026 | Joe B. Freels, Chief Commercial Officer | Grant/Award | 6,345 | $75.0K |
| Oct 30, 2026 | Gregory S. Hastings, VP, Animal Health | Exercise/Conversion | 1,211 | $14.8K |
| Oct 30, 2026 | Catherine E. Woteki | Exercise/Conversion | 1,776 | $21.7K |
| Oct 30, 2026 | Rafael A. Rodriguez | Exercise/Conversion | 1,776 | $21.7K |
| Oct 30, 2026 | Aashima Gupta | Exercise/Conversion | 1,776 | $21.7K |
| Oct 30, 2026 | Ronald D. Green | Exercise/Conversion | 1,776 | $21.7K |
| Oct 30, 2026 | Jeffrey D. Capello | Exercise/Conversion | 1,776 | $21.7K |
| Oct 30, 2026 | James C. Borel | Exercise/Conversion | 1,776 | $21.7K |
| Oct 23, 2026 | Gregory S. Hastings, VP, Animal Health | Exercise/Conversion | 287 | $3.4K |